Full Coverage

The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing (Business Wire)

yahoo.com
May 28, 2008
        
Story Timeline:  190 days

PARSIPPANY, N.J.----The Medicines Company announced receipt of a not approvable letter from the U.S. Food and Drug Administration on a supplemental New Drug Application for an additional dosing regimen for Angiomax® in the treatment of acute coronary syndromes initiated in the emergency department. [read full story]                    

Add Comment
Latest article on this story:

UPDATE 1-Medicines Co gets FDA not-approvable letter on Angiomax

 pharmiweb.co.uk May 28, 2008
First article on this story:

UPDATE 1-Medicines Co gets FDA not-approvable letter on Angiomax

 pharmiweb.co.uk May 28, 2008
Selected publications with coverage of this story:
yahoo.com pharmiweb.co.uk
RELATED
No documents found.